Leadership Training in Pharmaceutical Biotechnology
制药生物技术领导力培训
基本信息
- 批准号:8496803
- 负责人:
- 金额:$ 21.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): In the Leadership in Pharmaceutical Biotechnology training program, students are provided a broad-based education that cuts across traditional departmental and field-of-study boundaries, blending disciplines of pharmaceutical science, chemical engineering, biochemistry and chemistry. This program operates in close collaboration industry at both the local and national levels, and is currently supported by a broad-based group of corporate sponsors that leverage NIH support to provide interdisciplinary education in pharmaceutical biotechnology to graduate students in the University of Colorado's Departments of Chemical and Biological Engineering, Pharmaceutical Sciences, and Chemistry and Biochemistry. The Leadership in Pharmaceutical Biotechnology training program has seven major thrusts:
1. Lecture and laboratory coursework designed to provide a broad-based education in pharmaceutical biotechnology
2. Laboratory rotations
3. An industrial mentor program designed to enhance both recruitment and retention of students
4. A summer internship program with our industrial collaborators
5. Interdisciplinary thesis research
6. Leadership activities, including training in research ethics
7. Seminars and symposia.
These seven thrusts enable students to be educated in practical issues in pharmaceutical biotechnology (e.g., intellectual property issues, regulatory affairs and basic business concepts) as well as multidisciplinary scientific ones. This prepares students to perform well when they take subsequent positions in industry, academia, or government. To make sure that our research is rooted in practical problems, we rely heavily on our industrial colleagues as a source of new challenges that we may attempt to address. Students benefit from experiential training in non-academic settings, gaining an appreciation of the ever-changing biomedical and pharmaceutical industries. We incorporate active participation of our industrial mentors, industrial internships, and industrial seminar speakers to achieve this non-academic training.
描述(由申请人提供):在制药生物技术培训计划的领导,学生提供了一个基础广泛的教育,跨越传统的部门和研究领域的界限,混合制药科学,化学工程,生物化学和化学学科。该计划在地方和国家层面与行业密切合作,目前得到一个基础广泛的企业赞助商团体的支持,该团体利用NIH的支持,为科罗拉多大学化学和生物工程系、制药科学系以及化学和生物化学系的研究生提供制药生物技术方面的跨学科教育。 制药生物技术培训计划的领导力有七个主要目标:
1.讲座和实验室课程,旨在提供制药生物技术的广泛教育
2.实验室旋转
3.一个工业导师计划,旨在提高招聘和留住学生
4.与我们的工业合作伙伴一起开展暑期实习计划
5.跨学科论文研究
6.领导活动,包括研究道德培训
7.研讨会和专题讨论会。
这七个重点使学生能够在制药生物技术的实际问题(例如,知识产权问题、管理事务和基本商业概念)以及多学科科学问题。这为学生在工业,学术界或政府中担任后续职位时表现良好做好了准备。为了确保我们的研究植根于实际问题,我们在很大程度上依赖于我们的工业同事作为我们可能试图解决的新挑战的来源。学生受益于非学术环境中的体验式培训,获得不断变化的生物医学和制药行业的赞赏。我们将我们的工业导师,工业实习和工业研讨会发言人的积极参与,以实现这种非学术培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theodore W Randolph其他文献
Theodore W Randolph的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theodore W Randolph', 18)}}的其他基金
Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic Proteins
生物技术研究伙伴关系更新:治疗性蛋白质的聚集
- 批准号:
8616755 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7922043 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic Proteins
生物技术研究伙伴关系更新:治疗性蛋白质的聚集
- 批准号:
8439790 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic Proteins
生物技术研究伙伴关系更新:治疗性蛋白质的聚集
- 批准号:
9212808 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7069903 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7287793 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7678907 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic Proteins
生物技术研究伙伴关系更新:治疗性蛋白质的聚集
- 批准号:
9005860 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7484079 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
Aggregation of Protein Therapeutics: Mechanisms, Stability, and Interdiction
蛋白质治疗药物的聚集:机制、稳定性和拦截
- 批准号:
7881116 - 财政年份:2006
- 资助金额:
$ 21.7万 - 项目类别:
相似海外基金
REU Site: Research Experiences for American Leadership of Industry with Zero Emissions by 2050 (REALIZE-2050)
REU 网站:2050 年美国零排放工业领先地位的研究经验 (REALIZE-2050)
- 批准号:
2349580 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Standard Grant
Cultivating Persistence and Leadership Development in Science Master Teachers
培养科学名师的毅力和领导力发展
- 批准号:
2345144 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Continuing Grant
TEXL: Tracking Excellence in Leadership
TEXL:追踪卓越领导力
- 批准号:
ES/Y010779/1 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Research Grant
Conference: Cyberinfrastructure Leadership Academy: Team Science and Grand Challenges
会议:网络基础设施领导学院:团队科学和重大挑战
- 批准号:
2414440 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Standard Grant
Changing Institutions to Mitigate Gender Leadership Gaps: Power of Defaults
改变制度以缩小性别领导差距:违约的力量
- 批准号:
DP240101021 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Discovery Projects
HBCU-UP RAPID: HBCU Leadership Crisis on STEM Broadening Participation and Research Capacity Building - Impact and Implications
HBCU-UP RAPID:HBCU 在 STEM 扩大参与和研究能力建设方面的领导危机 - 影响和启示
- 批准号:
2344234 - 财政年份:2024
- 资助金额:
$ 21.7万 - 项目类别:
Standard Grant
STRADA (23008) Leadership Development Programme
STRADA (23008) 领导力发展计划
- 批准号:
10094757 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
EU-Funded
Global Leadership of Women in Web 3 (GLoW3) (2020-2024)
网络女性全球领导力 3 (GLoW3)(2020-2024)
- 批准号:
AH/X005526/1 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Fellowship
The tuition promoting critical dialogues beyond emotional conflicts: Nurturing the counselor-modeled- leadership
学费促进超越情感冲突的批判性对话:培养辅导员榜样的领导力
- 批准号:
23K02886 - 财政年份:2023
- 资助金额:
$ 21.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)